Clinical ResearchBiomarkers and Cardiac SurgeryIs a Pre-Operative Brain Natriuretic Peptide or N-Terminal Pro–B-Type Natriuretic Peptide Measurement an Independent Predictor of Adverse Cardiovascular Outcomes Within 30 Days of Noncardiac Surgery?: A Systematic Review and Meta-Analysis of Observational Studies
Biomarkers and Cardiac Surgery
Under an Elsevier user license
open archive
Key Words
perioperative myocardial infarction
brain natriuretic peptide
perioperative risk
Abbreviations and Acronyms
BNP
brain natriuretic peptide
LVEF
left ventricular ejection fraction
MI
myocardial infarction
NT-proBNP
N-terminal pro–B-type natriuretic peptide
OR
odds ratio
Cited by (0)
Continuing Medical Education (CME) is available for this article.
Dr. Karthikeyan is supported by a CIHR Scholarship (the Canada-HOPE Scholarship). Dr. Yusuf is supported by a Heart and Stroke Foundation Endowed Chair in Cardiovascular Research. Dr. Devereaux is supported by a Canadian Institutes of Health Research New Investigator Award and has received a grant-in-kind from Roche Diagnostics to evaluate NT-proBNP among patients undergoing noncardiac surgery.
Copyright © 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.